NovaLaka

Slow-release Transmucosal Drug Delivery Systems

Health Tech & Life Sciences
Non Active, Dec 2019 ceased to operate
Seed Jerusalem, Israel Founded 2015
LinkedIn
Last updated 2026-06-18
Total raised
$57K
Last: 2017-05
Stage
Seed
Founded
2015
Headcount
1
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

NovaLaka develops technology in the field of slow-release drug-delivery systems, specializing in transmucosal solutions for women's healthcare applications. The company has developed a polymeric composition that serves as a drug-delivery system specifically designed for mucosal tissue such as the eyes. The polymeric matrix gradually releases the desired medication directly to the area requiring treatment. NovaLaka's polymeric film can serve as a vehicle for any active ingredient, delivering it directly through the tissue effectively and in a controlled manner. In 2017, NovaLaka won the first prize at the Global Pitch of China.

Funding history · 1 round · $57K total

2017-05

Q&A

What is NovaLaka's primary focus in drug delivery systems?
NovaLaka specializes in developing slow-release transmucosal drug delivery systems, particularly for women's healthcare applications. Their technology involves a polymeric composition designed for mucosal tissue, such as the eyes, to gradually release medication.
When was NovaLaka founded?
NovaLaka was founded in October 2015.
What is NovaLaka's current operational status?
NovaLaka is currently inactive, having ceased operations in December 2019.
How much funding has NovaLaka raised in total?
NovaLaka has raised a total of $57,000.
When did NovaLaka secure its last funding round and who was an investor?
NovaLaka secured its last funding round in May 2017, with Israel Innovation Authority participating as an investor.
What recognition did NovaLaka receive in 2017?
In 2017, NovaLaka won the first prize at the Global Pitch of China.
In which sector does NovaLaka primarily operate?
NovaLaka's primary sector is Health Tech & Life Sciences.

Team · 1

Eva Smagacz
Founder · Co-Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

polymerssustained-releaseburnstopical-treatmentdrug-deliverypharmaceuticalspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)